COMMUNIQUÉS West-GlobeNewswire

Alder BioPharmaceuticals® to Present at the 18th Annual Needham Healthcare Conference
02/04/2019
BOTHELL, Wash., April 02, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Yield10 Bioscience CEO Oliver Peoples to Present at the Advanced Bioeconomy Leadership Conference on April 3, 2019
02/04/2019
WOBURN, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the agriculture and food [...]
Collegium Appoints Richard Malamut, M.D., as Chief Medical Officer
02/04/2019
STOUGHTON, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced the [...]
resTORbio Announces Initiation of Phase 1b/2a Trial of RTB101 in Parkinson’s Disease
02/04/2019
BOSTON, April 02, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat age-related [...]
United Health Products Announces 2018 Results
02/04/2019
HENDERSON, Nev., April 02, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC) (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound [...]
Rubius Therapeutics Announces Extensive Preclinical Data for Three Red Cell Therapeutic Oncology Programs at the 2019 American Association for Cancer Research Annual Meeting
02/04/2019
CAMBRIDGE, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is generating red blood cells and bioengineering them into an entirely new [...]
Selecta Biosciences to Present at the Needham & Company 18th Annual Healthcare Conference April 9, 2019
02/04/2019
WATERTOWN, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB) (“Selecta”), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on [...]
AMAG Pharmaceuticals to Present at Needham 18th Annual Healthcare Conference
02/04/2019
WALTHAM, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that Ted Myles, chief financial officer, will present at the Needham 18 th Annual Healthcare Conference in New [...]
HealthLynked Corp. Reports Full Year 2018 Results with 7% increase in Revenue
02/04/2019
NAPLES, Fla., April 02, 2019 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK ), late yesterday reported its results for the full year 2018. Full Year 2018 Highlights: 7% increase in revenue to $2.3 million compared [...]
Catalyst Biosciences Initiates a Phase 2b Trial of Dalcinonacog Alfa for the Treatment of Hemophilia B
02/04/2019
Currently enrolling individuals with severe hemophilia B SOUTH SAN FRANCISCO, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (Nasdaq:CBIO), today announced the initiation of enrollment in a Phase [...]
GBT Announces Participation at the H.C. Wainwright Global Life Sciences Conference
02/04/2019
SOUTH SAN FRANCISCO, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the H.C. Wainwright Global Life Sciences Conference in London [...]
Cyclerion Launches as Clinical-Stage Biopharmaceutical Company Harnessing the Power of Soluble Guanylate Cyclase (sGC) Pharmacology for Treatment of Serious and Orphan Diseases
02/04/2019
– $175 million committed from investors in private placement offering – – Trading of CYCN begins on Nasdaq today – CAMBRIDGE, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) today [...]
Galectin Therapeutics to Present at the 2019 H.C. Wainwright Global Life Sciences Conference
02/04/2019
NORCROSS, Ga., April 02, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Dr. Harold Shlevin, the Company’s [...]
AACR 2019 Presentations Highlight CX-2009, a First-In-Class Probody Drug Conjugate Targeting Novel Tumor Antigen, CD166
02/04/2019
- PROCLAIM-CX-2009 Dose Escalation Study Demonstrates Anti-Tumor Activity in Multiple Tumor Types - - Preclinical Studies Suggest Role of CD166 Expression Level in Anti-Cancer Activity and Potential for Combination of [...]
Imagin Medical Completes Assembly of i/Blue™ Imaging System Functional Unit
02/04/2019
VANCOUVER, British Columbia and BOSTON, April 02, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that it reached [...]
Leading Health Expert Bryce Wylde Joins Brain Armor® Advisory Board Focusing on Education and Innovation
02/04/2019
Brookfield, WI, April 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Trident Brands Inc. (OTCQB: TDNT) today announced that leading health expert, functional medicine clinician, and media personality Bryce Wylde has [...]
Celldex Presents Positive Interim Results from Phase 1 Study of CD40 Agonist CDX-1140 at American Association for Cancer Research (AACR) Annual Meeting 2019
02/04/2019
--CDX-1140 has achieved good systemic exposure without reaching a maximum tolerated dose to date-- --Addition of dendritic cell growth factor CDX-301 enhances cytokine response without additive toxicity at dose levels [...]
ALRT Aims For Dramatic Improvements in the Standard of Care For Diabetes
02/04/2019
Current treatment can be more effective with modern diabetes technology RICHMOND, Va., April 02, 2019 (GLOBE NEWSWIRE) -- “Clinical inertia causes diabetes to deteriorate in millions of patients,” said Sidney Chan, CEO [...]
Adaptimmune Presents Safety Data with Evidence of Tumor Necrosis in One Patient from ADP-A2AFP Study at American Association for Cancer Research (AACR) Meeting
02/04/2019
PHILADELPHIA and OXFORD, United Kingdom, April 02, 2019 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, presented initial safety data from two patients with [...]

Pages